![]() ChemomAb ChemomAb is a clinical stage biopharmaceutical company which develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases. | ||
Founding Date | Founding Date 1997 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Gaithersburg, US HQ | Locations Tel Aviv-Yafo, IL HQ |
Employees | Employees 691% increase | Employees N/A |
Valuation ($) | Valuation ($) 498.2 m | Valuation ($) 28.1 m |
Financial | ||
Revenue (est.) | Revenue (est.) $41k (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($88.1m) (FY, 2025) | Net income ($9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 47.7m | Total funding raised $ 15m |

ChemomAb is a clinical stage biopharmaceutical company which develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases.
View company